Vicarius Pharma
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Total Raised
$21.8MInvestors Count
1Deal Terms
1Vicarius Pharma Funding, Vicarius Pharma Valuation & Vicarius Pharma Revenue
1 Fundings
Vicarius Pharma's latest funding round was a Series A for $21.8M on August 14, 2017.
Vicarius Pharma's latest post-money valuation is from August 2017.
Sign up for a free trial to see Vicarius Pharma's valuations in August 2017 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
8/14/2017 | Series A | $21.8M | James Mullen, and Undisclosed Investors | 5 |
Date | 8/14/2017 |
|---|---|
Round | Series A |
Amount | $21.8M |
Investors | James Mullen, and Undisclosed Investors |
Valuation | |
Revenue | |
Sources | 5 |
Vicarius Pharma Deal Terms
1 Deal Term
Vicarius Pharma's deal structure is available for 1 funding round, including their Series A from August 14, 2017.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Vicarius Pharma Investors
1 Investors
Vicarius Pharma has 1 investors. James Mullen invested in Vicarius Pharma's Series A funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/14/2017 | 8/14/2017 | 1 Series A | Angel Investor (Individual) |
First funding | 8/14/2017 |
|---|---|
Last Funding | 8/14/2017 |
Investor | |
Rounds | 1 Series A |
Board Seats | |
Type | Angel Investor (Individual) |
Location |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.